803 related articles for article (PubMed ID: 25326748)
41. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting.
Pan M; Medina A; Suárez de Lezo J; Romero M; Segura J; Martín P; Suárez de Lezo J; Hernandez E; Mazuelos F; Ojeda S
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1165-70. PubMed ID: 22511299
[TBL] [Abstract][Full Text] [Related]
42. Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system.
Verheye S; Buysschaert I; Grube E
EuroIntervention; 2015 Dec; 11(8):860-7. PubMed ID: 26696454
[TBL] [Abstract][Full Text] [Related]
43. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
[TBL] [Abstract][Full Text] [Related]
44. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies.
Grundeken MJ; Asgedom S; Damman P; Lesiak M; Norell MS; Garcia E; Bethencourt A; Woudstra P; Koch KT; Vis MM; Henriques JP; Onuma Y; Foley DP; Bartorelli AL; Stella PR; Tijssen JG; de Winter RJ; Wykrzykowska JJ
EuroIntervention; 2013 Jun; 9(2):195-203. PubMed ID: 23360690
[TBL] [Abstract][Full Text] [Related]
45. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
[TBL] [Abstract][Full Text] [Related]
46. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
Rothman MT; Jain AK;
Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
[TBL] [Abstract][Full Text] [Related]
47. Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.
Sheiban I; Infantino VA; Colombo F; Bollati M; Omedè P; Moretti C; Sciuto F; Siliquini R; Chiadò S; Trevi GP; Biondi-Zoccai G
Catheter Cardiovasc Interv; 2009 Aug; 74(2):313-20. PubMed ID: 19496110
[TBL] [Abstract][Full Text] [Related]
48. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
[TBL] [Abstract][Full Text] [Related]
49. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
50. Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents.
Panoulas VF; Latib A; Naim C; Sato K; Ielasi A; Tespili M; Godino C; Testa L; Bedogni F; Colombo A
Catheter Cardiovasc Interv; 2015 Dec; 86(7):1168-76. PubMed ID: 26269415
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial.
van Houwelingen KG; van der Heijden LC; Lam MK; Kok MM; Löwik MM; Louwerenburg JW; Linssen GC; IJzerman MJ; Doggen CJ; von Birgelen C
Heart Vessels; 2016 Nov; 31(11):1731-1739. PubMed ID: 26747438
[TBL] [Abstract][Full Text] [Related]
52. Clinical efficacy and safety of biodegradable polymer-based sirolimus-eluting stents in patients with diabetes mellitus insight from the 4-year results of the create study.
Li Y; Han Y; Zhang L; Jing Q; Wang X; Yan G; Ma Y; Wang G; Wang S; Chen X; Yang L; Zhu G; Liu H; Jiang T
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1127-33. PubMed ID: 22945767
[TBL] [Abstract][Full Text] [Related]
53. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
[TBL] [Abstract][Full Text] [Related]
54. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
[TBL] [Abstract][Full Text] [Related]
55. Clinical Outcome of Double Kissing Crush Versus Provisional Stenting of Coronary Artery Bifurcation Lesions: The 5-Year Follow-Up Results From a Randomized and Multicenter DKCRUSH-II Study (Randomized Study on Double Kissing Crush Technique Versus Provisional Stenting Technique for Coronary Artery Bifurcation Lesions).
Chen SL; Santoso T; Zhang JJ; Ye F; Xu YW; Fu Q; Kan J; Zhang FF; Zhou Y; Xie DJ; Kwan TW
Circ Cardiovasc Interv; 2017 Feb; 10(2):e004497. PubMed ID: 28122805
[TBL] [Abstract][Full Text] [Related]
56. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group.
Brodie BR; Stuckey T; Downey W; Humphrey A; Bradshaw B; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Smith H; Edmunds J; Varanasi J; Simonton CA;
JACC Cardiovasc Interv; 2008 Aug; 1(4):405-14. PubMed ID: 19463338
[TBL] [Abstract][Full Text] [Related]
57. Rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: Two-year clinical outcome of the randomized ROTAXUS trial.
de Waha S; Allali A; Büttner HJ; Toelg R; Geist V; Neumann FJ; Khattab AA; Richardt G; Abdel-Wahab M
Catheter Cardiovasc Interv; 2016 Mar; 87(4):691-700. PubMed ID: 26525804
[TBL] [Abstract][Full Text] [Related]
58. Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions.
Chen L; Xu T; Xue XJ; Zhang JJ; Ye F; Tian NL; Chen SL
Int J Cardiovasc Imaging; 2018 Nov; 34(11):1685-1696. PubMed ID: 29981016
[TBL] [Abstract][Full Text] [Related]
59. Clinical outcomes after treating acute coronary syndrome patients with a drug-eluting stent: results from REWARDS-EMI (Endeavor for Myocardial Infarction Registry).
Dvir D; Barbash IM; Torguson R; Badr S; Sardi GL; Laynez-Carnicero A; Ben-Dor I; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2013; 14(3):128-33. PubMed ID: 23642502
[TBL] [Abstract][Full Text] [Related]
60. Impact of ultra-long second-generation drug-eluting stent implantation.
Honda Y; Muramatsu T; Ito Y; Sakai T; Hirano K; Yamawaki M; Araki M; Kobayashi N; Takimura H; Sakamoto Y; Mouri S; Tsutumi M; Takama T; Takafuji H; Tokuda T; Makino K
Catheter Cardiovasc Interv; 2016 Feb; 87(2):E44-53. PubMed ID: 26010548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
